相关概念视频
Amyloid Fibrils
6.9K
6.9K
Amyloid Fibrils
12.9K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
12.9K
Nephrotic Syndrome I : Introduction
967
Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
967
Cardiomyopathy IV: Restrictive Cardiomyopathy
798
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
798
您也可能阅读
相关文章
通过共同作者、期刊和引用图与本文相关的文章。
排序
Same author
Effects of Acoramidis on Kidney Function in Transthyretin Amyloid Cardiomyopathy.
Circulation. Heart failure·2026
Same author
Differential Transthyretin Stabilization in Patients With Wild Type and Variant Transthyretin Amyloidosis.
JACC. CardioOncology·2026
Same author
Outpatient worsening heart failure in transthyretin amyloid cardiomyopathy: Findings from ATTRibute-CM.
European journal of heart failure·2026
Same author
Baseline characteristics of patients with transthyretin amyloidosis with cardiomyopathy in the CARDIO-TTRansform trial of eplontersen.
European journal of heart failure·2026
Same author
Efficacy and Safety of Anselamimab in Immunoglobulin Light Chain Amyloidosis: Results From the Randomized CARES Trials.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Same author
Vutrisiran-Mediated Knockdown of Transthyretin in Patients with ATTR Amyloidosis.
Clinical pharmacokinetics·2026
Same journal
Rethinking anticoagulation intensity during extracorporeal membrane oxygenation.
Lancet (London, England)·2026
Same journal
Standard-dose unfractionated heparin versus low-dose unfractionated heparin and low-molecular-weight heparin in extracorporeal life support (RATE): an open-label, randomised, non-inferiority trial.
Lancet (London, England)·2026
Same journal
Inherited retinal degenerations: clinical phenotypes and emerging therapies.
Lancet (London, England)·2026
Same journal
Assisted dying and the silencing of medicine's next generation.
Lancet (London, England)·2026


